Khaitan & Co advised Supriya Lifescience on the offering. Supriya Lifescience Limited executed an inicitial public offering of an aggregating value at approx. INR 12,000 million comprising of...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here